The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine

about

The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine

Item

http://www.wikidata.org/entity/Q58707724

description

scientific article published on 26 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine

@en

The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine

@nl

type

Item

label

The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine

@en

The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine

@nl

prefLabel

The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine

@en

The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine

@nl

P1476

The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine

@en

P2093

Jean-Jacques Fournié

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Hallmarks of Cancer: The Next Generation

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation

The Cancer Genome Atlas Pan-Cancer analysis project

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors--insight into heterotrimeric IL-1 signaling complexes

The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1

Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules

Immunity, Inflammation, and Cancer

Targeting IL-33 in autoimmunity and inflammation

P304

2506

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2018.02506

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mary Poupot

P577

2018-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30416507

http://www.w3.org/2001/XMLSchema#string

P921

peptide

P932

6212549

http://www.w3.org/2001/XMLSchema#string